Dengue Tetravalent Vaccine, Live use while Breastfeeding
Medically reviewed by Drugs.com. Last updated on Oct 29, 2024.
Dengue Tetravalent Vaccine, Live Levels and Effects while Breastfeeding
Summary of Use during Lactation
Dengue vaccine is a live, attenuated vaccine indicated for children up to 16 years of age. No information is available on the clinical use of dengue vaccine during breastfeeding. However, the viruses were not detected in the milk of rats given the vaccine. If the mother requires dengue vaccine, it is not a reason to discontinue breastfeeding.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Dengue Tetravalent Vaccine, Live
Drug Class
Breast Feeding
Lactation
Milk, Human
Vaccines
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.